CV Lattes
Google Scholar Citations
Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas (FCF) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Biotecnologia from Universidade Estadual Paulista Júlio de Mesquita Filho (2008) and master's at Pharmacy from Universidade de São Paulo (2011). Has experience in Biochemistry, focusing on Molecular Biology, acting on the following subjects: cultura de células, equivalente dérmico, mini-gene, terapia gênica and melanoma b16f10. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Human melanoma presents extreme chemoresistance and poor prognosis with a higher risk of lymphatic and hematogenous metastases, besides six to nine months of survival rate. There is no drug efficient in spite of recent advances in therapy as the verumafenib and ipilimumab, since the patients have still shown chemoresistance and tumor recurrence. The current treatment, therefore, is still …
Human melanoma presents extreme chemoresistance and poor prognosis with a high risk of lymph node metastasis, hematogenous, and survival rate of six to nine months. Vemurafenib (PLX4032) caused great impact on therapeutic power because it was capable of inducing arrest of cell cycle and apoptosis , in addition to inhibiting the proliferation exclusively V600E positive cells in vitro syste…
| 2 / 1 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 2 | All Scholarships |
| Associated processes | |